GSKH — GSK plc ADRhedged
Data updated: 2026-08-21
GSKH — GSK plc ADRhedged. Europe Large Cap Blend / Core Health Care Equity · $737.44K AUM · 0.19% expense ratio. Holdings, fees, performance and SEC filings.
GSKH Fund Overview
GSKH — GSK plc ADRhedged is a US ETF managed by Precidian ETFs Trust, categorised as Europe Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Precidian ETFs Trust
- Category: Europe Large Cap Blend / Core Health Care Equity
- Assets under management: $737.44K
- 1-year return: 44.2%
- Ticker: GSKH
- SEC CIK: 0001499655
- SEC series ID: S000058701
- Share class ID: C000192683
GSKH Holdings
Top 2 holdings of GSK plc ADRhedged by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Gsk PLC | 96.79% |
| Dreyfus Trsry Securities | 2.57% |
GSKH Portfolio Allocation
Asset-class allocation of GSK plc ADRhedged by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 96.8% |
| Cash & Equivalents | 2.6% |
GSKH Performance
Total returns for GSKH (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 9.7% |
| 1 year | 44.2% |
GSKH Risk Information
Risk metrics for GSKH, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 24.1%
GSKH Costs and Fees
GSKH costs about $19 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.19%
- Gross expense ratio: 0.19%
- Portfolio turnover: 0%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
GSKH Cashflows
Over the 12 months to 2026-06, GSK plc ADRhedged had net inflows of $0, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $0 |
| 2026-05 | $0 |
| 2026-04 | $0 |
| 2026-03 | $0 |
| 2026-02 | $0 |
| 2026-01 | $0 |
GSKH Debt Constituents
No individual debt constituents are reported in GSK plc ADRhedged's latest SEC N-PORT filing.
GSKH Prospectus and SEC Filings
Official GSK plc ADRhedged filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-04-29
- Prospectus (485BPOS) — filed 2025-04-30
- Prospectus supplement (497) — filed 2024-09-27
- Portfolio holdings (N-PORT) — filed 2026-08-21
- Portfolio holdings (N-PORT) — filed 2026-05-21
- Portfolio holdings (N-PORT) — filed 2026-02-23
- Annual census (N-CEN) — filed 2026-03-11
Related Funds
Related funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.